NOVOCURE LTD's ticker is and the CUSIP is G6674U908. A total of 5 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,968,725 | -65.7% | 431,500 | -11.9% | 0.00% | -71.4% |
| Q2 2023 | $20,322,550 | -27.7% | 489,700 | +4.7% | 0.01% | -41.7% |
| Q1 2023 | $28,127,478 | +91.5% | 467,700 | +133.6% | 0.01% | +71.4% |
| Q4 2022 | $14,684,670 | +84.9% | 200,200 | +91.6% | 0.01% | +133.3% |
| Q3 2022 | $7,940,000 | +148.9% | 104,500 | +127.7% | 0.00% | +200.0% |
| Q2 2022 | $3,190,000 | – | 45,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 210,100 | $17,407,000 | 0.02% |
| HBK INVESTMENTS L P | 13,500 | $1,118,000 | 0.01% |
| SIMPLEX TRADING, LLC | 47,600 | $3,943,000 | 0.00% |
| JPMORGAN CHASE & CO | 53,900 | $4,466,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |